Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Salma Elfaki

Pediatrics Orlando, FL Medical Doctor

NPI 1093975674 CMS profile 276891

8236 Lee Vista Blvd, Suite I, Orlando, FL 32829

Open in the dashboard

General payments

$6,846

129 records reported · program years 2019–2025

Research payments

$3,655

Paid to them · 28 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,861,030 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Salma Elfaki of Orlando, FL is reported in the CMS Open Payments database as having received $6,846 across 129 general payments and $3,655 in research payments paid to them. Separately, studies naming them as principal investigator received $1,861,030 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $336 14
2024 General $381 12
2024 Research $1,272 9
2023 General $1,541 13
2023 Research $2,383 19
2022 General $876 14
2021 General $1,205 34
2020 General $425 21
2019 General $2,082 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Salma Elfaki
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Salma Elfaki were reported at $336. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Salma Elfaki Pediatrics median Middle half National median
2019 $2,082 $86 $31–$183 $163
2020 $425 $49 $22–$110 $114
2021 $1,205 $68 $27–$158 $132
2022 $876 $77 $30–$173 $149
2023 $1,541 $88 $33–$190 $160
2024 $381 $94 $34–$206 $164
2025 $336 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $1,918 20 payments
  2. Shionogi Inc $1,352 3 payments
  3. GlaxoSmithKline, LLC. $644 22 payments
  4. Welch Allyn $626 1 payment
  5. Baxter Healthcare $626 1 payment
  6. Tris Pharma Inc $338 15 payments
  7. Supernus Pharmaceuticals, Inc. $279 19 payments
  8. Merck Sharp & Dohme Corporation $177 10 payments
  9. Verrica Pharmaceuticals Inc. $156 3 payments
  10. Ironshore Pharmaceuticals Inc. $108 5 payments
  11. Other $621 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,103 121 payments
  2. Travel and Lodging $2,465 5 payments
  3. Debt forgiveness $1,252 2 payments
  4. Consulting Fee $25 1 payment
Products named General payments · program years 2019–2025
  1. BEXSERO $634 21 payments
  2. None $626 1 payment
  3. Dyanavel XR $338 15 payments
  4. PEDIARIX $226 11 payments
  5. QELBREE Psychology $166 16 payments
  6. YCANTH $156 3 payments
  7. EUCRISA $145 13 payments
  8. Qelbree Viloxazine Hydrochloride $113 3 payments
  9. GARDASIL 9 $109 6 payments
  10. Grastek $97 4 payments
  11. Other $1,546 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sanofi US Services Inc. $1,286 10 payments
  2. AbbVie, Inc. $1,272 9 payments
  3. Sanofi Pasteur Inc. $1,097 9 payments

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record